PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 47 filers reported holding PROQR THRAPEUTICS N V in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,299 | -26.1% | 19,461 | -7.9% | 0.00% | – |
| Q2 2023 | $34,223 | -31.3% | 21,126 | -9.6% | 0.00% | – |
| Q1 2023 | $49,791 | -41.4% | 23,377 | +2.2% | 0.00% | – |
| Q4 2022 | $85,000 | +400.0% | 22,876 | +2.2% | 0.00% | – |
| Q3 2022 | $17,000 | 0.0% | 22,376 | +3.5% | 0.00% | – |
| Q2 2022 | $17,000 | -15.0% | 21,626 | 0.0% | 0.00% | – |
| Q1 2022 | $20,000 | -88.2% | 21,626 | +1.7% | 0.00% | – |
| Q4 2021 | $170,000 | -3.4% | 21,265 | +0.9% | 0.00% | – |
| Q3 2021 | $176,000 | +23.9% | 21,065 | 0.0% | 0.00% | – |
| Q2 2021 | $142,000 | +0.7% | 21,065 | -1.1% | 0.00% | – |
| Q1 2021 | $141,000 | – | 21,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 1,237,400 | $5,197,000 | 1.55% |
| Prosight Management, LP | 255,000 | $1,071,000 | 0.50% |
| RTW INVESTMENTS, LP | 5,009,768 | $21,041,000 | 0.35% |
| Kerrisdale Advisers, LLC | 453,182 | $1,903,000 | 0.15% |
| Artal Group S.A. | 1,196,218 | $5,024,000 | 0.11% |
| COWEN AND COMPANY, LLC | 285,696 | $1,200,000 | 0.11% |
| Golden Green, Inc. | 16,999 | $71,000 | 0.07% |
| APOGEM CAPITAL LLC | 15,855 | $67,000 | 0.04% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,550,062 | $19,110,000 | 0.04% |
| ALTRINSIC GLOBAL ADVISORS LLC | 241,360 | $1,014,000 | 0.03% |